PCA-IN-1
PCA-IN-1 is a polyisoprenylated cysteinyl amide (PCA) inhibitor that acts on multiple KRAS mutant subtypes. PCA-IN-1 dissociates KRAS4B from its transport chaperones, prevents its localization to the plasma membrane, and blocks downstream oncogenic signaling pathways. PCA-IN-1 inhibits colony formation of KRAS-mutant lung cancer cells, induces sustained long-term growth inhibition, and suppresses cell migration. PCA-IN-1 is applicable to the research of KRAS-mutant lung cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C33H58N4O2S
- Masse moléculaire:574.90
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
KRAS(G12C) |
KRAS(G12A) |
PCA-IN-1 (PCAIs) (3 μM; 12 days) exerts broad anti-tumor activity by inhibiting colony formation in NCI-H23 KRASG12C and NCI-H23 KRASG12A cells[1].
NSL-YHJ-2-27 potently inhibits the viability of NCI-H23 KRASG12C (IC50 = 3.0 μM) and NCI-H23 KRASG12A (IC50 = 3.2 μM) cells, with consistent efficacy across different mutants[1].
PCA-IN-1 (26 d) exerts broad and sustained long-term growth inhibitory effects on NCI-H23 KRASG12C and NCI-H23 KRASG12A cells[1].
PCA-IN-1 (3 d) significantly inhibits the migration of NCI-H23 KRASG12C and NCI-H23 KRASG12A cells, whereas Sotorasib (HY-114277) only inhibits the migration of cells carrying the KRASG12C mutant[1].
PCA-IN-1 alters the transcriptome profile of KRAS-mutant NCI-H23 cells, with the changes enriched in signal transduction, cell adhesion and cancer-related pathways[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:NCI-H23 KRASG12C, NCI-H23 KRASG12A
-
Concentration:3 μM
-
Incubation Time:12 days
-
Result:Inhibited colony formation comparably to Sotorasib in NCI-H23 KRASG12C cells.
Showed significantly greater effectiveness in NCI-H23 KRASG12A cells than Sotorasib.
Chemical Information
-
Masse moléculaire 574.90
-
Formule C33H58N4O2S
-
SMILES
C/C(C)=C\CC/C(C)=C/CC/C(C)=C/CSCC(C(NC1CCCCCCC1)=O)NC(CN2CCN(CC2)C)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
PCA-IN-1 Related Classifications
HY-183625 Related Classifications
Powered by Bioz